Codes / ICD10CM / T44.4X5

T44.4X5 Adverse effect of predominantly alpha-adrenoreceptor agonists

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of predominantly alpha-adrenoreceptor agonists

Summary

This code identifies adverse effects resulting from exposure to medications that primarily target alpha-adrenoreceptors. Alpha-adrenoreceptor agonists influence vascular tone, blood pressure, and autonomic functions, and this code applies when these medications cause unintended harm or negative reactions, distinct from poisoning or underdosing scenarios.

Causes

Adverse effects may arise from therapeutic dosing, incorrect administration, or interactions with other substances. These reactions occur when the medication triggers unintended physiological responses, such as excessive vasoconstriction or autonomic dysfunction, even when used as prescribed.

Risk Factors

  • Concurrent use of medications affecting alpha-adrenoreceptor activity.
  • Pre-existing cardiovascular or metabolic conditions.
  • Age-related changes in drug metabolism or sensitivity (e.g., elderly or pediatric patients).
  • History of substance use or misuse.
  • Genetic variations affecting drug response.

Symptoms

  • Hypertension or hypotension.
  • Tachycardia or bradycardia.
  • Headache, dizziness, or confusion.
  • Nausea, vomiting, or abdominal pain.
  • Skin pallor or flushing.
  • Respiratory distress or bronchospasm.
  • Anxiety or restlessness.

Diagnosis

Diagnosis involves clinical evaluation, including a detailed medication history and assessment of symptoms. Laboratory tests may rule out other causes, and imaging or monitoring may assess cardiovascular or autonomic function. Documentation should specify the medication involved and the nature of the adverse effect.

Treatment Options

Management focuses on discontinuing the offending medication, providing supportive care (e.g., blood pressure monitoring, fluid management), and addressing specific symptoms. In severe cases, antidotes or interventions to counteract alpha-adrenergic effects may be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most adverse effects resolve with treatment, but ongoing monitoring may be needed to prevent recurrence. Follow-up ensures resolution of symptoms and adjustment of therapy if required.

Complications

Severe reactions may lead to cardiovascular instability, organ damage, or prolonged autonomic dysfunction. Rarely, untreated effects could result in stroke, heart failure, or respiratory compromise.

Lifestyle & Prevention

Patients should adhere to prescribed dosing, avoid interactions with other medications, and report new symptoms promptly. Healthcare providers should review medication lists regularly and educate patients on proper use and storage.

When to Seek Professional Help

Seek immediate care for severe symptoms like chest pain, difficulty breathing, or loss of consciousness. Contact a provider for persistent or worsening effects, even if mild.

Tips for Medical Coders

Document the specific alpha-adrenoreceptor agonist involved and the nature of the adverse effect (e.g., hypertension, bronchospasm). Ensure the code aligns with clinical findings and excludes poisoning or underdosing scenarios. Verify that the reaction is directly attributable to the medication and not another cause.

Book a walkthrough

T44.4X5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.